Journal ArticleAccountability in research · August 2025
The frequency of scientific retractions has grown substantially in recent years. However, thus far there is no standardized retraction notice format to which journals and their publishers adhere voluntarily, let alone compulsorily. We developed a rubric sp ...
Full textCite
Journal ArticleLife Sci Soc Policy · October 12, 2020
In the United States alone, the prevalence of AD is expected to more than double from six million people in 2019 to nearly 14 million people in 2050. Meanwhile, the track record for developing treatments for AD has been marked by decades of failure. But re ...
Full textLink to itemCite
Journal ArticleThe CRISPR journal · October 2020
In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In ...
Full textCite
Journal ArticleAm J Hum Genet · November 7, 2019
The advent of inexpensive, clinical exome sequencing (ES) has led to the accumulation of genetic data from thousands of samples from individuals affected with a wide range of diseases, but for whom the underlying genetic and molecular etiology of their cli ...
Full textOpen AccessLink to itemCite
Journal ArticleGigaScience · June 2019
BackgroundMany aspects of our lives are now digitized and connected to the internet. As a result, individuals are now creating and collecting more personal data than ever before. This offers an unprecedented chance for human-participant research r ...
Full textCite
Journal ArticleAm J Hum Genet · January 3, 2019
The use of whole-exome and whole-genome sequencing has been a catalyst for a genotype-first approach to diagnostics. Under this paradigm, we have implemented systematic sequencing of neonates and young children with a suspected genetic disorder. Here, we r ...
Full textOpen AccessLink to itemCite
Journal ArticleJournal of participatory medicine · January 2018
BackgroundUnlike aggregate research on groups of participants with a particular disorder, genomic research on discrete families' rare conditions could result in data of use to families, their healthcare, as well as generating knowledge on the huma ...
Full textOpen AccessCite
Journal ArticleNature reviews. Genetics · August 2015
Personalized and precision medicine initiatives explicitly call for researchers to treat research participants as partners. One way to realize that goal is by returning individual research results to participants. I propose a number of concrete steps that ...
Full textCite
Journal ArticleClinical genetics · April 2015
With the proliferation of affordable large-scale human genomic data come profound and vexing questions about management of such data and their clinical uncertainty. These issues challenge the view that genomic research on human beings can (or should) be fu ...
Full textCite
Journal ArticleCold Spring Harbor perspectives in medicine · July 2014
Human genetic diversity has long been studied both to understand how genetic variation influences risk of disease and infer aspects of human evolutionary history. In this article, we review historical and contemporary views of human genetic diversity, the ...
Full textOpen AccessCite
Journal ArticleClin Genet · April 2014
Skeletal dysplasias are challenging to diagnose because of their phenotypic variability, genetic heterogeneity, and diverse inheritance patterns. We conducted whole exome sequencing of a Turkish male with a suspected X-linked skeletal dysplasia of unknown ...
Full textLink to itemCite
Journal ArticlePloS one · January 2014
"One can't be of an enquiring and experimental nature, and still be very sensible."--Charles Fort. As the costs of personal genetic testing "self-quantification" fall, publicly accessible databases housing people's genotypic and phenotypic information are ...
Full textCite
Journal ArticleProceedings of the National Academy of Sciences of the United States of America · July 2012
Rapid advances in DNA sequencing promise to enable new diagnostics and individualized therapies. Achieving personalized medicine, however, will require extensive research on highly reidentifiable, integrated datasets of genomic and health information. To a ...
Full textCite
Journal ArticlePersonalized medicine · November 2011
The rapid emergence of whole-genome and whole-exome sequencing of research participants has helped to revive the debate about whether genetic and other 'omic' data should be returned to research participants, and if so, which data, under what circumstances ...
Full textCite
Journal ArticleGenetics in medicine : official journal of the American College of Medical Genetics · April 2010
Genetic testing for long QT syndrome exemplifies patenting and exclusive licensing with different outcomes at different times. Exclusive licensing from the University of Utah changed the business model from sole provider to two US providers of long QT synd ...
Full textCite
Journal ArticleMolecular diagnosis & therapy · April 2010
Access to one's own complete genome was unheard of just a few years ago. At present we have a smattering of identifiable complete human genomes, but the coming months and years will undoubtedly bring thousands more. What will this mean for the practice of ...
Full textCite
Journal ArticleDialogues in Clinical Neuroscience · 2010
The cost of a diploid human genome sequence has dropped from about $70M to $2000 since 2007-even as the standards for redundancy have increased from 7x to 40x in order to improve call rates. Coupled with the low return on investment for common single-nucle ...
Cite
Journal ArticleDialogues in clinical neuroscience · January 2010
The cost of a diploid human genome sequence has dropped from about $70M to $2000 since 2007--even as the standards for redundancy have increased from 7x to 40x in order to improve call rates. Coupled with the low return on investment for common single-nucl ...
Cite
Journal ArticleDialogues in Clinical Neuroscience · January 1, 2010
The cost of a diploid human genome sequence has dropped from about $70M to $2000 since 2007-even as the standards for redundancy have increased from 7x to 40x in order to improve call rates. Coupled with the low return on investment for common single-nucle ...
Cite
Journal ArticlePersonalized medicine · November 2009
I am a close observer of the Personal Genome Project (PGP) and one of the original ten participants. The PGP was originally conceived as a way to test novel DNA sequencing technologies on human samples and to begin to build a database of human genomes and ...
Full textCite
Journal ArticleTechnology Review · September 1, 2008
Misha Angrist states that companies and consumers need to follow the directions of regulatory authorities before accessing their genomes and personal-genomics service. Regulatory authorities need to understand that such services can provide significant ben ...
Cite
Journal ArticlePer Med · May 2006
A recent report from the British Royal Society on the prospects for personalized medicine provides a sobering assessment of the field and its prospects. The report contends that pharmacogenetics has little clinical relevance at the moment and will only pro ...
Full textLink to itemCite
Journal ArticlePhilos Trans R Soc Lond B Biol Sci · August 29, 2005
Advances in genome technology and other fruits of the Human Genome Project are playing a growing role in the delivery of health care. With the development of new technologies and opportunities for large-scale analysis of the genome, transcriptome, proteome ...
Full textLink to itemCite
Journal ArticleTrends in biotechnology · January 2005
Increasingly, gene expression data are becoming the currency of the realm in assessing disease prognosis. This has been especially evident in cancer, particularly those malignancies for which tumor samples are fairly accessible and understanding prognostic ...
Full textCite
Journal ArticleNature genetics · May 2002
Hirschsprung disease (HSCR), the most common hereditary cause of intestinal obstruction, shows considerable variation and complex inheritance. Coding sequence mutations in RET, GDNF, EDNRB, EDN3 and SOX10 lead to long-segment (L-HSCR) and syndromic HSCR bu ...
Full textCite
Journal ArticleGene · February 2002
Thymic stromal derived lymphopoietin receptor (TSLPR) is a novel receptor subunit that is related in sequence to the interleukin (IL)-2 receptor common gamma chain. TSLPR forms a heterodimeric complex with the IL-7 receptor alpha chain to form the receptor ...
Full textCite
Journal ArticleProceedings of the National Academy of Sciences of the United States of America · January 2000
Reduced penetrance in genetic disorders may be either dependent or independent of the genetic background of gene carriers. Hirschsprung disease (HSCR) demonstrates a complex pattern of inheritance with approximately 50% of familial cases being heterozygous ...
Full textCite
Journal ArticleGenome research · March 1999
Hirschsprung disease (HSCR) is a multigenic neurocristopathy clinically recognized by aganglionosis of the distal gastrointestinal tract. Patients presenting with aganglionosis in association with hypopigmentation are classified as Waardenburg syndrome typ ...
Cite
Journal ArticleOncogene · December 1998
Hirschsprung disease (HSCR), or congenital aganglionic megacolon, is the most frequent cause of congenital bowel obstruction. Germline mutations in the RET receptor tyrosine kinase have been shown to cause HSCR. Mice that carry null alleles for RET or for ...
Full textCite
Journal ArticleGenomics · March 1998
Congenital aganglionic megacolon, commonly known as Hirschsprung disease (HSCR), is the most frequent cause of congenital bowel obstruction. Germline mutations in the RET receptor tyrosine kinase have been shown to cause HSCR. Knockout mice for RET and for ...
Full textCite
Journal ArticleNature genetics · November 1996
Hirschsprung disease (HSCR), or congenital aganglionic megacolon, is the most common cause of congenital bowel obstruction with an incidence of 1 in 5000 live births. HSCR may be inherited as a single gene disorder with reduced penetrance or as a multigeni ...
Full textCite
Journal ArticleAmerican journal of medical genetics · June 1996
Congenital central hypoventilation syndrome (CCHS) usually occurs as an isolated phenotype. However, 16% of the index cases are also affected with Hirschsprung disease (HSCR). Complex segregation analysis suggests that CCHS is familial and has the same inh ...
Full textCite
Journal ArticleNature genetics · April 1996
Hirschsprung disease (HSCR) or colonic aganglionosis is a congenital disorder characterized by an absence of intramural ganglia along variable lengths of the colon resulting in intestinal obstruction. The incidence of HSCR is 1 in 5,000 live births. Mutati ...
Full textCite
Journal ArticleGenomics · December 1995
Molecules containing Src-homology 2 (SH2) and Src-homology 3 (SH3) domains are critical components of signal transduction pathways that serve to relay signals originating from the cell surface to the interior of the cell. Src-like adapter protein (SLAP) is ...
Full textCite
Journal ArticleHuman molecular genetics · May 1995
Hirschsprung disease (HSCR), or congenital aganglionic megacolon, is the most common cause of congenital bowel obstruction with an incidence of 1 in 5000 live births. Recently, linkage of an incompletely penetrant, dominant form of HSCR was reported, follo ...
Full textCite
Journal ArticleHum Mol Genet · October 1994
'Pure' autosomal dominant familial spastic paraplegia (SPG) is a neurodegenerative disease which clinically manifests as spasticity of the lower limbs. Dominantly inherited SPG is known to be clinically heterogenous and has been classified into late-onset ...
Full textLink to itemCite
Journal ArticleHuman molecular genetics · August 1994
Hirschsprung disease (HSCR) is a congenital disorder of unknown etiology characterized by the absence of enteric ganglia in the distal colon. We have ascertained a large, inbred, Mennonite kindred which demonstrates a high incidence of Hirschsprung disease ...
Full textCite
Journal ArticleNature genetics · August 1993
Hirschsprung disease (HSCR) is characterized by a congenital absence of enteric ganglia along a variable length of the intestine. Although long considered to be a multifactorial disease, we have identified linkage in a subset of five HSCR families to the p ...
Full textCite